Orbic ＜4684＞: 20,460 yen (-1210 yen)

A sharp decline. Financial results for the fiscal year ending 24/3 were announced the day before. Operating profit was 70.9 billion yen, up 13.5% from the previous fiscal year, which slightly exceeded the previous forecast of 70 billion yen. The fiscal year ending 25/3 is 78 billion yen, which is expected to increase 10.0% from the same period, and the consensus of about 80 billion yen seems to be slightly downward. The annual dividend is planned to be 320 yen, an increase of 20 yen from the previous fiscal year. Overall, surprises are limited, but the rate of increase in sales for the previous fiscal year ended 1-3 months remained in the 1-digit range, up 9.2% from the same period last year, and concerns about a slowdown in the growth rate are also somewhat conscious.

Shimano ＜7309＞: 25655 yen (+1,510 yen)

Significant continued growth. Financial results for the first quarter were announced the day before, and operating profit was 13.4 billion yen, down 52.1% from the same period last year, but the consensus seems to have been around 11 billion yen, and it has landed on an upward trend. Also, the full-year plan was revised upward from the previous 53 billion yen to 56.8 billion yen, down 32.1% from the previous fiscal year. The cost ratio improved due to progress in cost reduction, and it seems that SG&A expenses were also suppressed. We are in a situation where people are aware of the heightened accuracy of bottoming out in business performance. The implementation of a company stock repurchase with an upper limit of 1 million shares due to off-site transactions was also announced.

Nomura Micro ＜6254＞: 5460 yen (+705 yen)

Stop height. Upward revisions to earnings and dividend forecasts were announced the day before, and positive views prevail. Operating income for the fiscal year ending 2014/3 was revised upward from the previous forecast of 9.65 billion yen to 10.6 billion yen, up 61.8% from the previous fiscal year. The background is that construction progress of ultrapure water production equipment in each region has progressed smoothly, and that exchange rates have remained on a weak yen trend. The year-end dividend will also be raised from the previous plan of 100 yen to 190 yen, and the annual dividend will be distributed of 250 yen, an increase of 100 yen from the previous fiscal year.

Nidec (6594): 6462 yen (-283 yen)

Continued decline. Financial results for the fiscal year ending 24/3 were announced the day before. Operating profit was 163.1 billion yen, up 63.1% from the previous fiscal year, falling below the previous forecast of 180 billion yen. The main reason for the downturn was that structural reform costs were increased by approximately 15 billion yen. Meanwhile, the fiscal year ending 25/3 is 230 billion yen, which is expected to increase 41.0% from the same period, but the consensus of about 240 billion yen is slightly downward. There is a drastic increase in profit, but when anticipating structural reform costs of 59.8 billion yen for the previous fiscal year, the view that the actual rate of increase in profit is unsatisfactory prevails.

Ahresty ＜5852＞: 648 yen (-128 yen)

The sharp decline continued. The recording of impairment losses centered on the business assets of the Chinese subsidiary has been announced. Along with that, net profit and loss for the fiscal year ending 24/3 has completely reversed from the previously forecast surplus of 1.4 billion yen and was revised downward to a deficit of 9 billion yen. The year-end dividend was reduced from the previous plan of 10 yen to 5 yen, and the annual dividend was distributed of 15 yen, an increase of 5 yen from the previous fiscal year. It is a development where people are aware that the balance sheet has deteriorated due to the recording of a large deficit. Furthermore, operating profit has also been lowered from the previous forecast of 2.4 billion yen to 2.2 billion yen.

Ribomic [4591]: 86 yen (+3 yen)

A significant increase of 3 days. It has been announced to the Japanese Patent Office that a patent application relating to a conjugate (complex formation by chemical bonding) between aptamer and polyethyloxazoline and extending its half-life in blood has been completed. It was discovered that the conjugate of aptamer and polyethyloxazoline shows excellent internal dynamics and is an alternative compound for polyethylene glycol (PEG). Quality control of compounds is easy, and it is expected that they will be supplied at low cost in the future.

GENDA ＜9166＞: 3435 yen (+365 yen)

A significant increase of 3 days. It has been announced that 5/31 will be split at a ratio of 2 shares per share using 5/31 as the reference date. The purpose is to reduce the amount of money per investment unit, create an environment where it is easy to invest, improve the liquidity of the company's stock, and expand the investor base. At the same time, part of the Articles of Incorporation will be changed, and the total number of shares that can be issued will be raised from 127 million shares to 255 million shares. Also, it has been clarified that consolidated subsidiaries will make the amusement facility businesses Amex (Gifu City) and Plebi (Hitachi City, Ibaraki Prefecture) wholly owned subsidiaries.

Linkers ＜5131＞: 220 yen (+50 yen)

The stop is high. A business alliance has been formed with Ondec ＜7360＞, and it has been announced that they will cooperate with each other in the 3 areas of M&A support, platform development, and business matching. In addition to cooperatively developing M&A advisory services in the manufacturing field, they also provide Linkers' technology matching know-how and knowledge through platform development related to corporate alliances being promoted by Ondec. Also, Linkers' SaaS type business matching system “LFB” will be introduced on-deck.